Cosmos Health (COSM) Stock Price

Cosmos Health Price

NASDAQ·CLOSED
0.32
​
Market closed

Over the last 12 years Cosmos Health grew revenue by 42.9% annually, reaching 65.27 M USD. Earnings per share have grown at 10.9% per year over the last 7 years. For Cosmos Health, the net margin of -29.3% is down versus -14.2% a few years ago.

Cosmos Health stock price

Access this data via the Eulerpool API

Cosmos Health business model & stock analysis

Cosmos Holdings, Inc. engages in the importation, exportation, distribution, and sale of pharmaceutical products. The company is headquartered in Chicago, Illinois and currently employs 68 full-time employees. The company went IPO on 2010-05-19. The firm focuses on branded pharmaceuticals, over-the-counter (OTC) medicines and generic pharmaceuticals. The Company, through its subsidiary, Amplerissimo Ltd. (Amplerissimo), is engaged in the trading of products, providing representation and provision of consulting services to various sectors. The Company, through Amplerissimo, provides services, such as data mining, statistical data analysis, research and analysis, negotiating services, credit risk analysis, credit management, conducting case studies, introduction services, e-commerce consulting, marketing management consulting, expansion strategies consulting, information systems consulting and business management software consulting. SkyPharm S.A. (SkyPharm) is a subsidiary of Amplerissimo. SkyPharm is engaged in the trading of branded and generic pharmaceutical products and medicines across the European Union member states.

Frequently asked questions about Cosmos Health

7 analysts currently rate the Cosmos Health stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Cosmos Health to generate revenue of 80.80 M USD and earnings per share of -0.10 USD.

Converted at the current exchange rate, the Cosmos Health share trades at 0.29 EUR (0.32 USD).

The Cosmos Health share (COSM) is listed on 3 stock exchanges, including: NASDAQ (COSM), Frankfurt (V67.F), München (V67.MU).

The expected revenue of Cosmos Health is 80.80 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Cosmos Health is -4.02 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Cosmos Health is currently -3.28. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Cosmos Health stock.

The price-to-sales ratio (P/S) of Cosmos Health is currently 0.16. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Cosmos Health stock.

The Eulerpool Quality Score for Cosmos Health is 3/10.

The ISIN of Cosmos Health is US2214133058. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Cosmos Health is A2JSL2. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Cosmos Health is COSM. The ticker symbol is used to trade Cosmos Health shares on the stock exchange.

Fair ValueTerminal
0.27 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
400,440.55 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
May 19, 2010
ISIN
US2214133058
Cusip
221413206
Sedol
BFNL231
Market capitalization
6.15 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-3.28
P/Ee 2027
4.59
P/S
P/Se
0.16
EV/EBIT
—
P/B Ratio
0.33
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-49.86 %
Last updated Oct 9, 2026, 6:38 AM

Cosmos Health Ticker

FRANKFURT · V67.FMUNICH · V67.MUNASDAQ · COSM